This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Trualt Bioenergy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve the Standalone and Consolidated ....
TRUALT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.2 pts more than Nifty Microcap 250 and 3.0 pts more than its Other Agricultural Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Trualt Bioenergy has informed BSE that its Board of Directors will meet on Tuesday, November 11, 2025, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. The company has also confirmed that the trading window for its equity shares has been closed from October 1, 2025, and will remain closed until 48 hours after the results are declared. This is a standard regulatory filing under SEBI LODR Regulation 29(1) ahead of the Q2 earnings announcement.
No direct impact on shareholders from this filing itself; investors should watch for the actual Q2/H1 FY26 results on or after November 11, 2025, for performance cues. The closed trading window means insiders cannot trade until results are out.
| Q2 FY26 | Year ago | Change | |
|---|---|---|---|
| Revenue | ₹114.9 Cr | — | — |
| Profit after tax | −₹37.94 Cr | — | — |
From the company's XBRL filing, not from the text above. Operating profit and EBITDA margin are not shown for banks and lenders, whose other income is their business. No year-ago figures on this basis yet, so no comparison.